المؤلفون: Michaud, DS, Izard, J, Wilhelm-Benartzi, CS, You, DH, Grote, VA, Tjonneland, A, Dahm, CC, Overvad, K, Jenab, M, Fedirko, V, Boutron-Ruault, MC, Clavel-Chapelon, F, Racine, A, Kaaks, R, Boeing, H, Foerster, J, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Sacerdote, C, Sieri, S, Palli, D, Tumino, R, Panico, S, Siersema, PD, Peeters, PHM, Lund, E, Barricarte, A, Huerta, JM, Molina-Montes, E, Dorronsoro, M, Quiros, JR, Duell, EJ, Ye, WM, Sund, M, Lindkvist, B, Johansen, D, Khaw, KT, Wareham, N, Travis, RC, Vineis, P, Bueno-de-Mesquita, HB, Riboli, E

المصدر: Gut. 62(12):1764-1770

مصطلحات موضوعية: Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:127757075

المؤلفون: Wellenius GA, Wilhelm-Benartzi CS, Wilker EH, Coull BA, Suh HH, Koutrakis P, Lipsitz LA, Wellenius, Gregory A, Wilhelm-Benartzi, Charlotte S, Wilker, Elissa H, Coull, Brent A, Suh, Helen H, Koutrakis, Petros, Lipsitz, Lewis A

المصدر: Hypertension (0194911X); Mar2012, Vol. 59 Issue 3, p558-563, 6p

المؤلفون: Wilhelm-Benartzi CS; Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK Wilhelm-BenartziC@cardiff.ac.uk., Miller SE; Department of Paediatrics, University of Cambridge, Cambridge, UK.; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bruggraber S; Department of Paediatrics, University of Cambridge, Cambridge, UK., Picton D; Department of Paediatrics, University of Cambridge, Cambridge, UK., Wilson M; Department of Paediatrics, University of Cambridge, Cambridge, UK., Gatley K; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Chhabra A; Pharmacy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Marcovecchio ML; Department of Paediatrics, University of Cambridge, Cambridge, UK., Hendriks AEJ; Department of Paediatrics, University of Cambridge, Cambridge, UK., Morobé H; Katholieke Universiteit Leuven/ Universitaire Ziekenhuizen, Leuven, Belgium., Chmura PJ; Center for Protein Research, Kobenhavns Universitet Sundhedsvidenskabelige Fakultet, Kobenhavn, Denmark., Bond S; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Aschemeier-Fuchs B; Diabetes Centre for Children and Adolescents, Children's Hospital Auf der Bult, Hannover, Germany., Knip M; Research Program for Clinical and Molecular Metabolism, University of Helsinki Faculty of Medicine, Helsinki, Finland.; Pediatric Research Centre, University of Helsinki Children's Hospital, Helsinki, Finland., Tree T; Department of Immunobiology, King's College London, London, UK., Overbergh L; Katholieke Universiteit Leuven/ Universitaire Ziekenhuizen, Leuven, Belgium., Pall J; INNODIA Patient Advisory Committee, Madrid, Spain., Arnaud O; INNODIA Patient Advisory Committee, Paris, France., Haller MJ; Department of Pediatrics, University of Florida, Gainesville, Florida, USA., Nitsche A; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany., Schulte AM; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany., Mathieu C; Katholieke Universiteit Leuven/ Universitaire Ziekenhuizen, Leuven, Belgium., Mander A; Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK., Dunger D; Department of Paediatrics, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Institute of Metabolic Science, Cambridge University, Cambridge, UK.

المصدر: BMJ open [BMJ Open] 2021 Dec 07; Vol. 11 (12), pp. e053669. Date of Electronic Publication: 2021 Dec 07.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 1*/drug therapy, Adolescent ; Adult ; Antilymphocyte Serum/therapeutic use ; Blood Glucose ; Blood Glucose Self-Monitoring ; Child ; Clinical Trials, Phase II as Topic ; Humans ; Middle Aged ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Thymocytes ; Treatment Outcome ; Young Adult

المؤلفون: Willenbrock F; Department of Oncology, University of Oxford, Oxford, UK., Cox CM; Centre for Trials Research, Cardiff, UK., Parkes EE; Department of Oncology, University of Oxford, Oxford, UK., Wilhelm-Benartzi CS; Centre for Trials Research, Cardiff, UK., Abraham AG; Cross Cancer Institute, Edmonton, AB, Canada., Owens R; Oxford University Hospital NHS Trust, Oxford, UK., Sabbagh A; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Jones CM; University of Leeds & Leeds Cancer Centre, Leeds, UK., Hughes DLI; Department of Oncology, University of Oxford, Oxford, UK., Maughan T; Department of Oncology, University of Oxford, Oxford, UK., Hurt CN; Centre for Trials Research, Cardiff, UK., O'Neill EE; Department of Oncology, University of Oxford, Oxford, UK., Mukherjee S; Department of Oncology, University of Oxford, Oxford, UK. somnath.mukherjee@oncology.ox.ac.uk.

المصدر: British journal of cancer [Br J Cancer] 2021 Feb; Vol. 124 (3), pp. 581-586. Date of Electronic Publication: 2020 Oct 26.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*blood , Capecitabine/*therapeutic use , Chemokine CCL5/*blood , Chemoradiotherapy/*methods , Deoxycytidine/*analogs & derivatives , Pancreatic Neoplasms/*blood , Pancreatic Neoplasms/*therapy, Aged ; Cytokines/blood ; Deoxycytidine/therapeutic use ; Female ; Humans ; Induction Chemotherapy ; Male ; Middle Aged ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; ROC Curve ; Regression Analysis ; Treatment Outcome ; Gemcitabine

المؤلفون: Curry E; Department Surgery & Cancer, Imperial College London, London, United Kingdom., Zeller C; Department Surgery & Cancer, Imperial College London, London, United Kingdom., Masrour N; Department Surgery & Cancer, Imperial College London, London, United Kingdom., Patten DK; Department Surgery & Cancer, Imperial College London, London, United Kingdom., Gallon J; Department Surgery & Cancer, Imperial College London, London, United Kingdom., Wilhelm-Benartzi CS; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Ghaem-Maghami S; Department Surgery & Cancer, Imperial College London, London, United Kingdom., Bowtell DD; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Brown R; Department Surgery & Cancer, Imperial College London, London, United Kingdom. b.brown@imperial.ac.uk.; Institute of Cancer Research, Sutton, United Kingdom.

المصدر: Cancer research [Cancer Res] 2018 Mar 15; Vol. 78 (6), pp. 1383-1391. Date of Electronic Publication: 2018 Jan 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Ovarian Epithelial/*drug therapy , DNA Methylation/*genetics , Drug Resistance, Neoplasm/*genetics , Ovarian Neoplasms/*drug therapy, Carcinoma, Ovarian Epithelial/genetics ; Chromatin/genetics ; Chromatin Immunoprecipitation ; CpG Islands ; DNA Methylation/drug effects ; Drug Resistance, Neoplasm/drug effects ; Epigenesis, Genetic ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Silencing ; Histone Code ; Histones ; Humans ; Ovarian Neoplasms/genetics ; Promoter Regions, Genetic

المؤلفون: Phelps DL; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Borley JV; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Flower KJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Dina R; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Darb-Esfahani S; Institute of Pathology, Charité Universitätsmedizin, Berlin 10117, Germany., Braicu I; Department of Gynaecology, Virchow Campus, Universitätsmedizin, Berlin, Germany., Sehouli J; Department of Gynaecology, Virchow Campus, Universitätsmedizin, Berlin, Germany., Fotopoulou C; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.; Department of Gynaecology, Virchow Campus, Universitätsmedizin, Berlin, Germany., Wilhelm-Benartzi CS; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Gabra H; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Yazbek J; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Chatterjee J; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Ip J; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Khan H; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Likos-Corbett MT; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Brown R; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK., Ghaem-Maghami S; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.

المصدر: British journal of cancer [Br J Cancer] 2017 May 09; Vol. 116 (10), pp. 1287-1293. Date of Electronic Publication: 2017 Mar 28.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Promoter Regions, Genetic*, Carcinoma/*genetics , Fallopian Tube Neoplasms/*genetics , Myosin-Light-Chain Kinase/*genetics , Ovarian Neoplasms/*genetics , Peritoneal Neoplasms/*genetics, Biomarkers, Tumor/genetics ; Carcinoma/surgery ; CpG Islands ; Cytoreduction Surgical Procedures ; DNA Methylation ; Fallopian Tube Neoplasms/surgery ; Female ; Humans ; Kaplan-Meier Estimate ; Neoplasm, Residual ; Ovarian Neoplasms/surgery ; Peritoneal Neoplasms/surgery ; Proportional Hazards Models ; Risk Assessment/methods ; Survival Rate

المؤلفون: Coombes RC; Imperial College Healthcare NHS Trust & Imperial College, London, Hammersmith Hospital, London, UK., Caballero OL; Ludwig Collaborative Laboratory, Ludwig Institute for Cancer Research, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Shousha S; Imperial College Healthcare NHS Trust & Imperial College, London, Charing Cross Hospital, London, UK., Ghaem-Maghami S; Imperial College Healthcare NHS Trust & Imperial College, London, Charing Cross Hospital, London, UK., Woodley-Barker L; Imperial College Healthcare NHS Trust & Imperial College, London, Charing Cross Hospital, London, UK., Wilhelm-Benartzi CS; Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK., Neville AM; Ludwig Institute for Cancer Research, New York, NY, USA.

المصدر: Oncoscience [Oncoscience] 2017 Apr 28; Vol. 4 (3-4), pp. 33-40. Date of Electronic Publication: 2017 Apr 28 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals LLC Country of Publication: United States NLM ID: 101636666 Publication Model: eCollection Cited Medium: Print ISSN: 2331-4737 (Print) Linking ISSN: 23314737 NLM ISO Abbreviation: Oncoscience Subsets: PubMed not MEDLINE

المؤلفون: Wilhelm-Benartzi CS; CRUK Imperial Centre, Department of Surgery and Cancer, Imperial College London, UK; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, UK. Electronic address: c.wilhelm-benartzi@imperial.ac.uk., Mt-Isa S; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, UK., Fiorentino F; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, UK., Brown R; Epigenetics Unit, Department of Surgery and Cancer, Imperial College London, UK., Ashby D; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, UK.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2017 Feb; Vol. 110, pp. 49-61. Date of Electronic Publication: 2016 Dec 21.

نوع المنشور: Journal Article; Review; Systematic Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*analysis , Neoplasms/*chemistry, Clinical Trials as Topic ; Humans ; Research Design

المؤلفون: Mahendru AA; Fetal Medicine Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Department of Fetal Medicine, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK., Wilhelm-Benartzi CS; ICTU-Cancer Clinical Trials Unit, Department of Surgery and Cancer, Imperial College London, London, UK., Wilkinson IB; Division of Experimental Medicine and Immunotherapeutics, Addenbrooke's Hospital, University of Cambridge, Box 98, Cambridge, CB20QQ, UK., McEniery CM; Division of Experimental Medicine and Immunotherapeutics, Addenbrooke's Hospital, University of Cambridge, Box 98, Cambridge, CB20QQ, UK., Johnson S; SPD Development Company Ltd., Bedford, UK., Lees C; Department of Fetal Medicine, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK. christoph.lees@imperial.nhs.uk.; Department of Surgery and Cancer, Institute of Developmental and Reproductive Biology, Imperial College London, London, W12 0HS, UK. christoph.lees@imperial.nhs.uk.; Department of Development and Regeneration, University Hospitals Leuven, KU Leuven, Campus Gasthuisberg, 3000, Leuven, Belgium. christoph.lees@imperial.nhs.uk.

المصدر: Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2016 Oct; Vol. 294 (4), pp. 867-76. Date of Electronic Publication: 2016 Jul 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8710213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0711 (Electronic) Linking ISSN: 09320067 NLM ISO Abbreviation: Arch Gynecol Obstet Subsets: MEDLINE

مواضيع طبية MeSH: Gestational Age*, Embryo Implantation/*physiology , Ovulation/*physiology , Ultrasonography, Prenatal/*methods, Adult ; Crown-Rump Length ; Female ; Humans ; Menstruation ; Pregnancy ; Pregnancy Trimester, First ; Prospective Studies

المؤلفون: Bonito NA; Department of Surgery & Cancer, Imperial College London, London W12 0NN, UK., Borley J; Department of Surgery & Cancer, Imperial College London, London W12 0NN, UK., Wilhelm-Benartzi CS; Department of Surgery & Cancer, Imperial College London, London W12 0NN, UK., Ghaem-Maghami S; Department of Surgery & Cancer, Imperial College London, London W12 0NN, UK., Brown R; Department of Surgery & Cancer, Imperial College London, London W12 0NN, UK.; Institute of Cancer Research, Sutton, London SM2 5NG, UK.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Jun 15; Vol. 22 (12), pp. 3097-3104. Date of Electronic Publication: 2016 Jan 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Biomarkers, Tumor/*genetics , Cisplatin/*therapeutic use , DNA Methylation/*genetics , Drug Resistance, Neoplasm/*genetics , MSX1 Transcription Factor/*genetics , Neoplasms, Glandular and Epithelial/*drug therapy , Neoplasms, Glandular and Epithelial/*genetics , Ovarian Neoplasms/*drug therapy , Ovarian Neoplasms/*genetics, Carcinoma, Ovarian Epithelial ; Cell Line, Tumor ; Cell Proliferation/genetics ; CpG Islands/genetics ; Cyclin-Dependent Kinase Inhibitor p21/biosynthesis ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Neoplasms, Glandular and Epithelial/mortality ; Ovarian Neoplasms/mortality ; RNA Interference ; RNA, Small Interfering/genetics